Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of eye conditions, such as glaucoma, ocular hypertension, and retinal diseases; and contact lenses for therapeutic use. The Surgical segment provides tools and technologies for the treatment of cataracts, and vitreous and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices. The company was founded in 1853 and is headquartered in Vaughan, Canada.

Bernard Chauvin

Bausch + Lomb Corporation

Lensmarket.bg offers a variety of contact lenses, including daily, monthly, and specialty lenses, along with care solutions, tailored for users' specifications.

Lensmarket.bg

LaserView is involved in eye surgery services, self-described as a reference in this field.

LaserView

成都爱迪眼科医院 is a national level three eye hospital that focuses on various eye diseases and corrective procedures.

Metric
Company Name	Bausch + Lomb Corporation	Lensmarket.bg	LaserView	成都爱迪眼科医院
Symbol	BLCO
MSH ID	COM:BAUSCH	BG:LENSMARKET	BR:COM:LASERVIEW	COM:028AIDI
Market	STOCKS	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare	Consumer Goods	Healthcare & Health Services	Healthcare & Health Services
Industry	Medical - Instruments & Supplies	Optical Retail	Medical Services	Healthcare
Country	CA	BG	BR	CN
Stage
Employee Count	13.30K
Website	bausch.com	lensmarket.bg	laserview.com.br	028aidi.com
LinkedIn		lensmarket-bg		%E6%88%90%E9%83%BD%E7%88%B1%E8%BF%AA%E7%9C%BC%E7%A7%91%E5%8C%BB%E9%99%A2%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B8
Founders

Metric
Market Cap	5.43B
Enterprise Value
Monthly Web Traffic		355.66K
Web Traffic Growth		-0.38
Valuation
Raised Capital

Metric
Revenue	4.15B
Revenue (LTM)
Revenue (NTM)
Gross Profit	2.50B
EBITDA	601M
Operating Income	130M
Net Income	-260M
EPS	-0.74
Diluted EPS	-0.74
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.96
Operating Profit Margin	0.12
EBITDA Margin	0.14
Net Profit Margin	-0.00
Return on Equity	0.02
Return on Assets	-0.00
Return on Capital Employed	0.05

COM:BAUSCH

Bausch + Lomb Corporation

Last Close

19.81

22/11 21:00

Market Cap

5.43B

Beta: -

Volume Today

363.23K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	-23.54
P/B Ratio	0.71
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	1.64
EV Multiple	17.67

Metric
Days Sales Outstanding	72.01
Days Payables Outstanding	82.99
Days Inventory Outstanding	1.62K
Operating Cycle	1.70K
Cash Conversion Cycle	1.07K
Asset Turnover	0.34

Metric
Operating Cash Flow	-17M
Free Cash Flow	-198M
Cash Flow to Debt	0.05
Operating Cash Flow/Sales	0.13
Free Cash Flow Yield	-0.00

Metric
Cash & Equivalents	331M
Accounts Receivable	-121M
Inventory	1.03B
Goodwill	4.58B
Debt to Capitalization	1.05
Debt to Assets	0.34
Current Ratio	1.78
Quick Ratio	1.03

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.02
R&D to Revenue	0.08
SG&A to Revenue